D-0717-2022 Class II Terminated
FDA drug recall D-0717-2022 was initiated by Akorn, Inc. on Sep 8, 2021 and is designated Class II. Reason for recall: Lack of Assurance of Sterility The recall status is terminated (terminated Sep 28, 2023). Affected quantity: 62,331 box.
Recall details
- Product Type
- Drugs
- Report Date
- Mar 30, 2022
- Initiation Date
- Sep 8, 2021
- Termination Date
- Sep 28, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 62,331 box
Product description
TheraTears Extra (sodium carboxymethylcellulose) 0.25% Lubricant Eye Drops, 30 Sterile Single-Use Vials per box, Akorn Consumer Health, A Division of Akorn, Inc., Ann Arbor, MI 48105. NDC 58790-010-30
Reason for recall
Lack of Assurance of Sterility
Distribution pattern
Nationwide within theUSA
Code information
Lot #: 913012, 913013, 913014, Exp. Date 1/31/2023
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0717-2022
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026